XML 37 R26.htm IDEA: XBRL DOCUMENT v3.26.1
Goodwill and Other Purchased Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2026
Intangible Asset, Goodwill and Other [Abstract]  
Changes to goodwill by segment
Changes to goodwill by segment were as follows (in millions):
Life
Science
Clinical
Diagnostics
Total
Balances as of December 31, 2025
Goodwill$493.2 $421.8 $915.0 
Accumulated impairment losses(41.8)(293.4)(335.2)
Goodwill, net451.4 128.4 579.8 
Foreign currency adjustments(2.7)— (2.7)
Period change, net
(2.7)— (2.7)
Balances as of March 31, 2026
Goodwill490.5 421.8 912.3 
Accumulated impairment losses(41.8)(293.4)(335.2)
Goodwill, net$448.7 $128.4 $577.1 
Schedule of identifiable purchased intangible assets with definite lives
Information regarding our identifiable purchased intangible assets with finite and indefinite lives is as follows (in millions):
March 31, 2026
Weighted-Average Amortization Period (in years)
Purchase
Price
Accumulated
Amortization
Net Carrying
Amount
Customer relationships/lists4.2$114.7 $(107.3)$7.4 
Developed product technology10.5313.2 (163.4)149.8 
Licenses2.959.6 (50.9)8.7 
Tradenames3.36.0 (5.2)0.8 
Covenants not to compete0.26.5 (6.4)0.1 
     Total purchased intangible assets $500.0 $(333.2)$166.8 
 December 31, 2025
Weighted-Average Amortization Period (in years)
Purchase
Price
Accumulated
Amortization
Net Carrying
Amount
Customer relationships/lists4.4$115.6 $(107.7)$7.9 
Developed product technology10.7315.8 (160.0)155.8 
Licenses3.159.8 (50.3)9.5 
Tradenames3.66.0 (5.1)0.9 
Covenants not to compete0.56.5 (6.3)0.2 
     Total purchased intangible assets $503.7 $(329.4)$174.3 
Finite-lived Intangible Assets Amortization Expense [Table Text Block]
Amortization expense related to purchased intangible assets was as follows (in millions):

Three Months Ended
 March 31,
 20262025
Amortization expense$5.9 $5.0